NovaBridge BiosciencesNBP
那斯達克 · USD
1.97
+0.33
(+19.82%)
盤中 06/30 01:59 (UTC+8)
06/30 01:59 (UTC+8)
NovaBridge BiosciencesNBP
1.97
+0.33
(+19.82%)
財務數據
損益表
- 0.02
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -94.85
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2019/Q4 | 2019/Q3 | |
營業收入淨額 | - | - | - | - | - | - | - | 104 | 2,019 |
營業成本 | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | 104 | 2,019 |
營業費用 | 72,900 | 8,989 | 7,114 | 5,266 | 13,371 | 12,412 | 17,140 | 51,962 | 40,404 |
研發費用 | 55,658 | 3,176 | 3,294 | 777 | 6,030 | 4,475 | 5,203 | 39,627 | 42,428 |
推銷及管理費用 | 17,242 | 5,813 | 3,820 | 4,489 | 7,341 | 7,937 | 11,937 | 12,335 | -2,024 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - |
營業利益 | -72,900 | -8,989 | -7,114 | -5,266 | -13,371 | -12,412 | -17,140 | -51,858 | -38,385 |
其他收入及費用 | - | - | - | - | - | - | - | -1,932 | 8,705 |
利息費用 | - | - | - | - | - | - | - | 84 | 63 |
稅前純益 | -72,858 | -6,828 | -5,504 | -3,150 | -10,844 | -20,491 | -8,942 | -53,873 | -29,745 |
所得稅 | - | - | - | - | - | - | - | - | - |
稅後純益 | -30,787 | -6,828 | -5,504 | -3,150 | -9,062 | -20,491 | 25,422 | -53,873 | -29,745 |
基本每股稅後盈餘(元) | - | - | -0.07 | -0.05 | - | -0.25 | 0.30 | - | - |
稀釋每股稅後盈餘(元) | - | - | -0.07 | -0.05 | - | -0.25 | 0.30 | - | - |
基本平均股數(千股) | - | - | 81699.00 | 81599.00 | - | 81495.00 | 80932.00 | - | - |
稀釋平均股數(千股) | - | - | 81699.00 | 81599.00 | - | 81495.00 | 80932.00 | - | - |
還原基本每股稅後盈餘(元) | - | - | -0.07 | -0.05 | - | -0.25 | 0.30 | - | - |
還原稀釋每股稅後盈餘(元) | - | - | -0.07 | -0.05 | - | -0.25 | 0.30 | - | - |
還原基本平均股數(千股) | - | - | 81,699 | 81,599 | - | 81,495 | 80,932 | - | - |
還原稀釋平均股數(千股) | - | - | 81,699 | 81,599 | - | 81,495 | 80,932 | - | - |
EBITDA(千元) | -30,571 | -6,612 | -5,504 | -3,150 | -8,849 | -20,295 | 25,422 | -53,123 | -29,159 |